Quality Of Life Of The Patients With Ovarian Cancer

Similar documents
Quality of Life and Survivorship:

Evaluation of Quality of Life and Menopausal Symptoms in Women with Breast Cancer in Northern Iran

A RANDOMISED CONTROLLED TRIAL OF CONQUER FEAR DELIVERED IN A GROUP FORMAT

Assessment of quality of life in patients with breast cancer receiving chemotherapy

Women s Health Development Unit, School of Medical Science, Health Campus, Universiti Sains Malaysia b

Health-related quality of life a prospective cohort study in phase I oncology trial participants 1

DEVELOPMENT THE VALIDATION OF INDONESIAN VERSION OF SF-36 QUESTIONNAIRE IN CANCER DISEASE. Dyah Ariani Perwitasari

Session 6: Choosing and using HRQoL measures vs Multi-Attribute Utility Instruments QLU-C10D and EQ-5D as examples

Prof. Dr. Aydın ÖZSARAN

QUT Digital Repository: This is the author version published as:

Unmet supportive care needs in Asian women with breast cancer. Richard Fielding Division of Behavioural Sciences School of Pubic Health, HKU

Background. 2 5/30/2017 Company Confidential 2015 Eli Lilly and Company

Introducing the QLU-C10D A preference-based utility measure derived from the QLQ-C30

Quality of Life Instrument - Breast Cancer Patient Version

Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients

The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer

A Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group (NCIC CTG), the European Organization for Research and

Nutritional Counselling, cancer Outcome and Quality of Life!

Palliative Care: Expanding the Role Throughout the Patient s Journey. Dr. Robert Sauls Regional Lead for Palliative Care

Multidimensional fatigue and its correlates in hospitalized advanced cancer patients

FATIGUE SYMPTOM INVENTORY BIBLIOGRAPHY. Prepared by Kristine A. Donovan, Ph.D. and Paul B. Jacobsen, Ph.D.

Health-Related Quality of Life in Brain Tumor Patients Treated with Surgery: Preliminary Result of a Single Institution

DIAGNOSTIC SIGNIFICANCE OF CHANGES IN SERUM HUMAN EPIDIDYMIS EPITHELIAL SECRETORY PROTEIN 4 AND CARBOHYDRATE ANTIGEN 125 IN ENDOMETRIAL CARCINOMA

Change in health-related quality of life over 1 month in cancer patients with high initial levels of symptoms and problems

J Clin Oncol 25: by American Society of Clinical Oncology INTRODUCTION

(RGN, BN,FETC,MA,Independent Prescriber)

ANZGOG Update. Symptom Working Group. Presentation prepared by Michael Friedlander

Original Article on Palliative Radiotherapy

Changes of Quality of Life after Gastric Cancer Surgery

RESPONSE (NCT )

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

Supporting Family Caregivers through Palliative Care

Virtual Journal Club: Front-Line Therapy and Beyond Recent Perspectives on ALK-Positive Non-Small Cell Lung Cancer.

The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation study of the Thai version

Transitioning to palliative care: How early is early palliative care?

Symptom Benefit Committee. Chicago May 2018 F. Hilpert/JE Kurtz

Palliative Care The Benefits of Early Intervention

Carcinosarcoma Trial rial in s a in rare malign rare mali ancy

Original Research. Background

nutrition and cancer Weight loss and Quality of Life (QoL) Nutrition and QoL wound healing Surgery & RT hospital stay rehospitalisations Malabsorption

INTEGRATIVE ONCOLOGY

How to fight a silent killer: Lessons learned from Ovarian Cancer. Stephen A. Cannistra, M.D.

The Quality of Life of Chinese Middle-Aged Male Patients with Gastric Carcinoma After Total Gastrectomy and Nursing Intervention

Incorporating the patient voice in sarcoma research:

LARYNGEAL CANCER IN EGYPT: QUALITY OF LIFE MEASUREMENT WITH DIFFERENT TREATMENT MODALITIES

Quality of life in ovarian cancer survivors

Health Technology Assessment (HTA)

receive adjuvant chemotherapy

Wilms Tumour A brief note for the parents

10th anniversary of 1st validated CaPspecific

The outcome of non-muscle invasive urinary bladder tumour at Makassed General Hospital

NCCN Guidelines for Ovarian Cancer V Meeting on 11/15/17

Managing Panic Disorder with Cognitive Behavior Therapy in Bangladesh: A Single Case Study

UNIVERSITY OF MINNESOTA

UPDATE IN THE MANAGEMENT OF INVASIVE CERVICAL CANCER

Impact of Chemotherapy-Induced Nausea and Vomiting on Quality of Life in Indonesian Patients With Gynecologic Cancer

Implementing Patient Report Outcome Data in Clinical Trials Analysis

WITHDRAWING FROM BUPRENORPHINE THERAPY

Improving quality of care for patients with ovarian and endometrial cancer Eggink, Florine

Watching and waiting : what it means for patients. Dr Christian Aldridge Consultant Dermatologist Cwm Taf NHS Trust

In Woong Han 1, O Choel Kwon 1, Min Gu Oh 1, Yoo Shin Choi 2, and Seung Eun Lee 2. Departments of Surgery, Dongguk University College of Medicine 2

Original Article INTRODUCTION. Abstract

Comparison of Quality of Life and Sexuality between Cervical Cancer Survivors and Healthy Women

Impact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma

COS SPORTS MEDICINE CONCUSSION ASSESSMENT FORM BASELINE TEST Adapted from SCAT3

Unmet palliative care needs in heart failure heart failure. Dr Claire Hookey

Updates on the Conflict of Postoperative Radiotherapy Impact on Survival of Young Women with Cancer Breast: A Retrospective Cohort Study

Assessing older patients with hematological malignancies

Symptom clusters using the EORTC QLQ-C15-PAL in palliative radiotherapy

At present, chemotherapy is the treatment of choice for

Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Evaluating the Total Costs of Chemotherapy-Induced Toxicity: Results from a Pilot Study with Ovarian Cancer Patients

Symptom clusters using the Brief Pain Inventory in patients with breast cancer

Reliability and validity of the Cancer Therapy Satisfaction Questionnaire in lung cancer

Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series

Trial record 1 of 1 for:

Clinical Study Synopsis

Preoperative Quality of Life in Patients with Gastric Cancer

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

The Relationship of Pain, Uncertainty, and Hope in Taiwanese Lung Cancer Patients

BR-MA, GI-MA and OM-MA: Immunoassays for the Tumor Markers CA15-3, CA19-9 and CA125

A Brief Information Sheet On Opioid Effects Improves Quality Of Life In Cancer Patients On Opioids

Marcello Deraco M.D. Responsible Peritoneal Malignancies

HYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee

CPAG Summary Report for Clinical Panel Policy 1630 Bendamustine-based chemotherapy for first-line treatment of Mantle cell lymphoma (MCL) in adults

Correlation between the Symptoms and the Quality of Life in Prostate Cancer Patients Underwent Radiotherapy

Anota et al. Health and Quality of Life Outcomes 2014, 12:32

3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis

Update on PARP inhibitors

One Palliative Care Annual Report

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

IOTA and Models for Screening for Ovarian Cancer

RESEARCH ARTICLE. Mozhgan Patoo 1 *, Abbas Ali Allahyari 1 Ali Reza Moradi 2, Mehrdad Payandeh 3. Abstract. Introduction

Measurement and Descriptive Statistics. Katie Rommel-Esham Education 604

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Chika Nwachukwu, Ph.D. MS IV Radiation Oncology Rotation

The Danish Palliative Care Trial (DanPaCT), a randomised trial of early palliative care in cancer. Results of the primary analysis

Anterior resection syndrome following sphincterpreserving resection in the UK population

ratio in patients treated by sorafenib alone decreased after treatment (P<0.05), while CD 8

Transcription:

ISPUB.COM The Internet Journal of Oncology Volume 7 Number 2 M Zamurovic, Z Perisic Citation M Zamurovic, Z Perisic.. The Internet Journal of Oncology. 2009 Volume 7 Number 2. Abstract PURPOSE: The goal of this research is the analysis of the quality of life of the patients with advanced ovarian cancer in the period after radical surgery and chemotherapy.patients AND METHODS: 60 patients with advanced ovarian cancer who underwent radical surgery in the time period 2008-2009 at the University Clinic for Obstetrics and Gynecology Narodni Front and after that received adjuvant chemotherapy were selected for this research. The patients filled out the Short Form-36 (SF-36) Health Survey Questionnaire, the EORTC Quality of Life Questionnaire C30 (QLQ-C30) and Hamilton questionnaire.results: Based on the SF 36 questionnaires, it has been calculated that the score for general health of the patients equals 56.03. The physical role and emotional role have received the lowest scores, of 23.33 and 26.66 respectively. Based on the QLQ-C30 questionnaire, it has been determined that one third of the patients had assigned the lowest possible score. The average score for depression was 8.9 out of 26, and 10.81 out of 24 for anxiety. CONCLUSION: The analysis of the quality of life of the patients during the disease can point to symptoms, i.e. factors leading to deterioration in the quality of life. Timely recognition of these factors and taking preventive measures could have positive influence on improving the quality of life during the disease. INTRODUCTION Ovarian cancer is one of the ten most frequent malignant tumors in female population. Particular importance lies in fact that this tumor has high rate of mortality. Every year there are 204000 new cases of this cancer worldwide while 125000 women die every year [1]. Ovarian cancer accounts for 4-5% of all malignant tumors in female population and participates with 4.2% in mortality structure. In developed countries share of ovarian cancer is 28.7% in all female genital tract tumors. References often refer to ovarian carcinoma as the gynaecological killer number one in modern world [2]. Malignant ovarian tumors are considered to be among the worst problems in gynecological oncology because of the lack of screening methods, impossibility of early detection, unspecific symptoms of the disease, extremely malignant course and high mortality rate. During the period of treatment, remission or relapse of the disease, the patients face the symptoms of the disease on a daily basis, which affects their psychological, social and emotional state, having influence on the quality of their own lives and the lives of their families. For this reason, attention is increasingly devoted to the improvement of the quality of the patients lives during the treatment and remission. In order to gain insight into the most common psycho-somatic symptoms influencing the quality of life, questionnaires adapted to all social groups of patients have been developed. The questionnaires have been validated and are already in use in most major oncological centers in the world the patients fill them out before each medical procedure, therapy or check-up. In this way, a broader analysis of the quality of life is started, with the goal of defining the problems in each individual case, in order to act on them and improve the quality of the patients lives during the disease and its treatment [3]. In this way, it is possible to evaluate the quality of life during therapy, and subsequently, during the remission periods, and plan medical treatment which would have positive effect on the quality of life, or at least prevent the aggravation of the quality of life of the patients in the advanced stages of the disease [4]. The goal of this research is the analysis of the quality of life of the patients with advanced ovarian cancer in the period after radical surgery and chemotherapy. PATIENTS AND METHODS 60 patients with advanced ovarian cancer who underwent radical surgery at the University Clinic for Obstetrics and Gynecology Narodni Front in the time period 2008-2009 and after that received adjuvant chemotherapy were selected 1 of 5

for this research. The patients filled out the Short Form-36 (SF-36) Health Survey Questionnaire, the EORTC Quality of Life Questionnaire-C30 version 3.0 (QLQ-C30) and Hamilton questionnaire, under the supervision of researchers, without time limitations. The statistical analysis of the collected data was performed afterwards, and it included data entry, recoding, calculating the basic scoring scales, transformation of the basic scales into 0-100 scales. At the end of the statistical data processing, score verification was performed to eliminate the possible errors which could have occurred during data entry, programming and processing, leading to incorrect scale score. Higher scores denominate better quality of life. The results obtained are shown in diagram format. RESULTS Reliability of measurement tools and internal consistency of the questions was performed prior to the analysis of the quality of life based on the health questionnaires. Reliability was tested using Cronbach analysis. High value of Cronbach s alpha coefficient was noted for each questionnaire analyzed. For SF 36 α = 0,844, for QLQ C30 α = 0,708, for Hamilton's scale of depressivenes α = 0,717 and for Hamilton's scale for anxiety α = 0,739. High values of Cronbach s alpha coefficient testify to the questionnaires reliability. THE SHORT FORM 36 (SF-36) HEALTH SURVEY QUESTIONNAIRE SF 36 health questionnaire is a general health questionnaire developed to measure eight most important items with eight groups of questions. The following items were measured: physical functioning, physical role, somatic pain, general health, vitality, social functioning, emotional role and mental health. The following diagram shows how the patients rated their general health, according to the results of SF 36 questionnaire (please refer to diagram 1). Figure 1 Diagram 1. SF-36 health questionnaire. The physical and emotional roles have the lowest scores: 23.33 and 26.66 respectively. As many as 70% of the patients rated their physical role with a zero, while 63.3% of the patients rated their emotional role with a zero. Although general health has the highest score, it is only 56.03. This score is practically in the middle of the scale, which means that general health is rated as midiocre. THE EORTC QUALITY OF LIFE QUESTIONNAIRE C30 (QLQ-C30) QLQ-C30 questionnaire has been designed specifically for cancer patients. The following diagram shows how the patients rate their health in the items measured by QLQ-C30 (please refer to diagram 2). Figure 2 Diagram 2. QLQ C-30 questionnaire. The lowest score, i.e. zero for physical functioning was present in 21.9% of the patients, while zero score for physical role was present in 18.8% of the patients. The zero score for the social role was present in almost one third of 2 of 5

the patients (28.1%), while 12.5% of the patients rated their emotional role as zero. As many as 56.3% of the patients assigned zero value to their cognitive function. Zero score for nausea and vomiting was present in as many as 40.6% patients. Exactly the same percentage of patients (40.6) assigned zero to loss of appetite and insomnia. As many as 59.4% rated their problems with constipation with zero, while 71.9% did so for diarrhea. Zero score for somatic pain was present in 15.6% of the patients, and 28.1% for dyspnoea. 65.6% of the patients assigned the value of zero to their financial problems. Apparently, one third of the patients reported that their physical functioning, social role and emotional role were equal to zero, i.e. very poor. More than one third of the patients complained about nausea, vomiting and loss of apetite. As many as 59.4% assigned zero to constipation and 71.9% to diarrhea, which is also very poor. 21.9% of the patients assigned zero to their general health, while 12.5% of the patients rated their general health as mediocre. HAMILTON EVALUATION OF ANXIETY AND DEPRESSION The degree of anxiety and depression was evaluated using the Hamilton s questionnaire. The results are given in the following diagram (please refer to diagram 3). Figure 3 Diagram 3. Hamilton questionnaire The average score for depression was 8.9 (the maximum score is 26) while the average score for anxiety was 10.81 (the maximum score is 24), which means that the patients were more or less depressed and anxious about their health. DISCUSSION Treatment of ovarian cancer includes radical surgery with maximal cytoreduction which is a very complex and difficult operation with long postoperative recovery, during which patients must deal with facts about spreading of disease, prognosis and survival. Painful symptoms of malignant disease thus acquire an additional dimension - emotional, i.e. psychological dimension, which is connected to subjective preoccupations about further treatment, discomforts, continuing life with disease, loss of reproductive function (in younger patients), but also about death, which in a special way enlarges already present symptoms and discomforts. According to literature, more than 40% of women survive more than five years [5]. This practically means that, during period of treatment, remission or relapse, these patients have to deal with symptoms of disease every day, which can change their psychological, social and emotional condition, affecting significantly not only quality of their life but of their family members as well. This study indicated that subjective rating of life quality of our patients is between bad and average values on analyzed quality life scale. Analysis of results acquired from SF-36 questionnaire showed that physical (23.33) and emotional part (26.66) have the lowest score. 70% of patients had physical part score equal to zero while 63.3% patients graded their emotional part with zero. Analysis of results QLQ-C30 questionnaire concluded that patients complain the most about nausea, vomiting, diarrhea, constipation, exhaustion and fatigue, and that these discomforts significantly affect life quality and change part of physical functioning as well as emotional part. High rate of depression and anxiety is acquired by analysis of results of Hamilton questionnaire, which in addition amplifies psychological component which completely changes life quality of these patients. The analysis has shown that the quality of life of the patients in advanced stages of ovarian cancer was rated either as mediocre or poor, the patients are experiencing deterioration of their physical, emotional and psychological function, which further impairs their normal functioning and contributes to worsening of their quality of life during the treatment period. According to data available form references about the quality of life of the patients during all phases of the disease point to a significant drop in all items measured by the questionnaires about the quality of life [ 6, 7, 8, 9, 10,11]. Evaluation and identification of all factors influencing the 3 of 5

quality of life of ovarian cancer patients could help in overcoming the difficulties and symptoms connected with them, and thus contribute to the improvement of the quality of life of the patients during the survival period. This is why in recent years a trend is present in the world literature which calls for analysis of the quality of patient s life in each phase of the disease, with special emphasis on the dynamics of deterioration of quality of life. It is also important to analyze the factors which cause this deterioration, in order to be able to act preventively upon these factors, i.e. to influence in a positive way the improvement of life quality during all phases of the disease or survival period. Examination of the quality of life during each phase of the disease may inform the physician of the development of the symptoms which trouble the patient most, in order to prevent them to the extent possible. In this way, a positive influence on the quality of life could be made, with the aim of its improvement during the survival period. References 1. Sun CC, Ramirez PT, Bodurka DC. Quolity of lafe for patients with epithelial ovarian cancer. Nat Clin Pract Oncol. 2007 Jan; 4(1): 18-29. 2. Ozols RF. Treatement Goals in Ovarian Cancer. Int J Gynecol Cancer. 2005 May-Jun; 15 Suppl 1: 3-11. 3. Fox SW, Lyon D. Symptom Clusters and Quolity of Life in Survivours of Ovarian Cancer. Cancer Nurs 2007 Sept- Oct; 30(5): 354-61. 4. Sun CC, Ramirey PT, Bodurka DC. Quolity of Life for Patients With Epithelial Ovarian Cancer. Nat Clin Oncol 2007 Jan; 4(1): 18-29. 5. Penson R, Cella D, Wenzel L. Quality of life in ovarian cancer. J Reprod Med. 2005; 50(6):407-16. 6. Stein K, Sugar C, Velikova G, Stark D. Putting the 'Q' in quality adjusted life years (QALYs) for advanced ovarian cancer - An approach using data clustering methods and the internet. Eur J Cancer. 2007 Jan;43(1):104-13. Epub 2006 Nov 13. 7. Ferrell B, Cullinane CA, Ervine K, Melancon C, Uman GC, Juarez G. Perspectives on the impact of ovarian cancer: women's views of quality of life. Oncol Nurs Forum. 2005 Nov 3;32(6):1143-9. 8. Kauff ND, Hurley KE, Hensley ML, Robson ME, Lev G, Goldfrank D, Castiel M, Brown CL, Ostroff JS, Hann LE, Offit K, Barakat RR. Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up. Cancer. 2005 Jul 15;104(2):314-20. 9. Penson R, Cella D, Wenzel L. Quolity of Life in Ovarian Cancer. J Reprod Med 2005 Jun; 50(6): 407-16. 10. Ding Y, Zhu YL, Zhang MF. Quality of life of Chinese patients with ovarian malignancies during chemotherapy under condition of no recurrence. Cancer Nurs. 2007 May- Jun; 30(3):243-51. 11. Lockwood-Rayermann S, Donovan HS, Rambo D, Kuo CW. Women's awareness of ovarian cancer risks and symptoms. Am J Nurs. 2009 Sep; 109(9):36-45; quiz 46. 4 of 5

Author Information Milena Zamurovic, Phd MD Specialists Of Obstetrics & Gynecology, University Clinic for Obstetrics & Gynecology Narodni Front Zivko Perisic, Phd MD Specialists Of Obstetrics & Gynecology, University Clinic for Obstetrics & Gynecology Narodni Front 5 of 5